{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:14:51Z","timestamp":1786994091367,"version":"build-2736575974"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Intensiva (English Edition)"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.medine.2022.03.007","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T10:37:01Z","timestamp":1707475021000},"page":"26-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"S1","title":["F\u00e1rmacos vasoactivos en el tratamiento del shock s\u00e9ptico"],"prefix":"10.1016","volume":"46","author":[{"given":"D.","family":"Andaluz-Ojeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.L.","family":"Cant\u00f3n-Bulnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Pey Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Garnacho-Montero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medine.2022.03.007_bib0365","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA."},{"key":"10.1016\/j.medine.2022.03.007_bib0370","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s13054-018-2144-4","article-title":"Refractory septic shock: our pragmatic approach","volume":"22","author":"Nandhabalan","year":"2018","journal-title":"Crit Care."},{"key":"10.1016\/j.medine.2022.03.007_bib0375","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1007\/s00134-010-2045-8","article-title":"Vascularhyporesponsiveness to vasopressors in septic shock: from bench to bedside","author":"Levy","year":"2010","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.medine.2022.03.007_bib0380","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1056\/NEJMra002709","article-title":"Mechanisms of disease: the pathogenesis of vasodilatory shock","volume":"345","author":"Landry","year":"2001","journal-title":"N Engl J Med."},{"key":"10.1016\/j.medine.2022.03.007_bib0385","first-page":"392","article-title":"Cardiac dysfunction in severe sepsis and septic shock","volume":"15","author":"Zanotti-Cavazzonia","year":"2009","journal-title":"Curr Opin Crit Care."},{"key":"10.1016\/j.medine.2022.03.007_bib0390","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.medine.2022.03.007_bib0395","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1097\/00003246-200008000-00007","article-title":"Effects of perfusion pressure on tissue perfusion in septic shock","volume":"28","author":"LeDoux","year":"2000","journal-title":"Crit Care Med."},{"key":"10.1016\/j.medine.2022.03.007_bib0400","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/01.CCM.0000157788.20591.23","article-title":"Increasing mean arterial pressure in patients with septic shock: efects on oxygen variables and renal function","volume":"33","author":"Bourgoin","year":"2005","journal-title":"Crit Care Med."},{"key":"10.1016\/j.medine.2022.03.007_bib0405","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1056\/NEJMoa1312173","article-title":"High versus low blood-pressure targets in patients with septic shock","volume":"370","author":"Asfar","year":"2014","journal-title":"N Engl J Med."},{"key":"10.1016\/j.medine.2022.03.007_bib0410","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/CIRCULATIONAHA.107.728840","article-title":"Inotropes and vasopressors: review of physiology and clinical use in cardiovascular disease","volume":"118","author":"Overgaard","year":"2008","journal-title":"Circulation."},{"key":"10.1016\/j.medine.2022.03.007_bib0415","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1378\/chest.103.6.1826","article-title":"Norepinephrine or dopamine for the treatment of hyperdynamic septic shock?","volume":"103","author":"Martin","year":"1993","journal-title":"Chest."},{"key":"10.1016\/j.medine.2022.03.007_bib0420","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1097\/00003246-200008000-00012","article-title":"Effect of norepinephrine on the outcome of septic shock","volume":"28","author":"Martin","year":"2000","journal-title":"Crit Care Med."},{"key":"10.1016\/j.medine.2022.03.007_bib0425","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1056\/NEJMoa0907118","article-title":"Comparison of dopamine and norepinephrine in the treatment of shock","volume":"362","author":"De Backer","year":"2010","journal-title":"N Engl J Med."},{"key":"10.1016\/j.medine.2022.03.007_bib0430","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/CCM.0b013e31823778ee","article-title":"Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis","volume":"40","author":"De Backer","year":"2012","journal-title":"Crit Care Med."},{"key":"10.1016\/j.medine.2022.03.007_bib0435","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1177\/0885066610396312","article-title":"Norepinephrine or dopamine for septic shock: systematic review of randomized clinical trials","volume":"27","author":"Vasu","year":"2012","journal-title":"J Intensive Care Med."},{"key":"10.1016\/j.medine.2022.03.007_bib0440","doi-asserted-by":"crossref","first-page":"e0129305","DOI":"10.1371\/journal.pone.0129305","article-title":"Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis","volume":"10","author":"Avni","year":"2015","journal-title":"PLoS One."},{"key":"10.1016\/j.medine.2022.03.007_bib0445","first-page":"CD003709","article-title":"Vasopressors for hypotensive shock","volume":"2","author":"Gamper","year":"2016","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.medine.2022.03.007_bib0450","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/01.CCM.0000201896.45809.E3","article-title":"Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) study","volume":"34","author":"Sakr","year":"2006","journal-title":"Crit Care Med."},{"key":"10.1016\/j.medine.2022.03.007_bib0455","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1007\/s00134-008-1219-0","article-title":"A comparison of epinephrine and norepinephrine in critically ill patients","volume":"34","author":"Myburgh","year":"2008","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.medine.2022.03.007_bib0460","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0140-6736(07)61344-0","article-title":"Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial","volume":"370","author":"Annane","year":"2007","journal-title":"Lancet."},{"key":"10.1016\/j.medine.2022.03.007_bib0465","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1177\/1060028019843664","article-title":"Norepinephrine and Vasopressin Compared With Norepinephrine and Epinephrine in Adults With Septic Shock","volume":"53","author":"Menich","year":"2019","journal-title":"Ann Pharmacother."},{"key":"10.1016\/j.medine.2022.03.007_bib0470","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1161\/01.CIR.95.5.1122","article-title":"Vasopressin deficiency contributes to the vasodilation of septic shock","volume":"95","author":"Landry","year":"1997","journal-title":"Circulation."},{"key":"10.1016\/j.medine.2022.03.007_bib0475","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/00000542-200203000-00011","article-title":"Beneficial effects of short-term vasopressin infusion during severe septic shock","volume":"96","author":"Patel","year":"2002","journal-title":"Anesthesiology."},{"key":"10.1016\/j.medine.2022.03.007_bib0480","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1007\/s001340101014","article-title":"The efects of vasopressin on hemodynamics and renal function in severe septic shock: a case series","volume":"27","author":"Holmes","year":"2001","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.medine.2022.03.007_bib0485","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa067373","article-title":"Vasopressin versus norepinephrine infusion in patients with septic shock","volume":"358","author":"Russell","year":"2008","journal-title":"N Engl J Med."},{"key":"10.1016\/j.medine.2022.03.007_bib0490","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1001\/jama.2016.10485","article-title":"Efect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial","volume":"316","author":"Gordon","year":"2016","journal-title":"JAMA."},{"key":"10.1016\/j.medine.2022.03.007_bib0495","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1007\/s00134-019-05620-2","article-title":"Vasopressin in septic shock: an individual patient data meta-analysis of randomised controlled trials","volume":"45","author":"Nagendran","year":"2019","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.medine.2022.03.007_bib0500","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1097\/01.CCM.0000178182.37639.D6","article-title":"Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study","volume":"33","author":"Alban\u00e8se","year":"2005","journal-title":"Crit Care Med."},{"key":"10.1016\/j.medine.2022.03.007_bib0505","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/bja\/aen017","article-title":"Effects of shortterm simultaneous infusion of dobutamine and terlipressin in patients with septic shock: the DOBUPRESS study","volume":"100","author":"Morelli","year":"2008","journal-title":"Br J Anaesth."},{"key":"10.1016\/j.medine.2022.03.007_bib0510","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1007\/s00134-018-5267-9","article-title":"Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial","volume":"44","author":"Liu","year":"2018","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.medine.2022.03.007_bib0515","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12871-020-00965-4","article-title":"Terlipressin for the treatment of septic shock in adults: a systematic review and meta-analysis","volume":"20","author":"Huang","year":"2020","journal-title":"BMC Anesthesiol."},{"key":"10.1016\/j.medine.2022.03.007_bib0520","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/CCM.0000000000001380","article-title":"A selective V(1A) receptor agonist, selepressin, is superior to arginine vasopressin and to norepinephrine in ovine septic shock","volume":"44","author":"He","year":"2016","journal-title":"Crit Care Med."},{"key":"10.1016\/j.medine.2022.03.007_bib0525","doi-asserted-by":"crossref","first-page":"e525","DOI":"10.1097\/CCM.0000000000000300","article-title":"The selective vasopressin type 1a receptor agonist selepressin (FE 202158) blocks vascular leak in ovine severe sepsis","volume":"42","author":"Maybauer","year":"2014","journal-title":"Crit Care Med."},{"key":"10.1016\/j.medine.2022.03.007_bib0530","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s13054-017-1798-7","article-title":"Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients","volume":"21","author":"Russell","year":"2017","journal-title":"Crit Care."},{"key":"10.1016\/j.medine.2022.03.007_bib0535","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1001\/jama.2019.14607","article-title":"Effect of selepressin vs placebo on ventilator-and vasopressor-free days in patients with septic shock: The SEPSIS-ACT randomized clinical trial","volume":"322","author":"Laterre","year":"2019","journal-title":"JAMA."},{"key":"10.1016\/j.medine.2022.03.007_bib0540","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/jama.2017.2841","article-title":"Association Between US Norepinephrine Shortage and Mortality Among Patients With Septic Shock","volume":"317","author":"Vail","year":"2017","journal-title":"JAMA."},{"key":"10.1016\/j.medine.2022.03.007_bib0545","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.chest.2020.11.051","article-title":"Effect of Phenylephrine Push Before Continuous Infusion Norepinephrine in Patients With Septic Shock","volume":"159","author":"Hawn","year":"2021","journal-title":"Chest."},{"key":"10.1016\/j.medine.2022.03.007_bib0725","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1056\/NEJMoa1704154","article-title":"Angiotensin II for the treatment of vasodilatory shock","volume":"377","author":"Khanna","year":"2017","journal-title":"N Engl J Med."},{"key":"10.1016\/j.medine.2022.03.007_bib0550","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1164\/rccm.201911-2172OC","article-title":"Renin and Survival in Patients Given Angiotensin II for Catecholamine-Resistant Vasodilatory Shock. A Clinical Trial","volume":"202","author":"Bellomo","year":"2020","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.medine.2022.03.007_bib0730","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1592\/phco.30.7.702","article-title":"Methylene blue for the treatment of septic shock","volume":"30","author":"Paciullo","year":"2010","journal-title":"Pharmacotherapy."},{"key":"10.1016\/j.medine.2022.03.007_bib0560","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0022-3565(25)32823-5","article-title":"Alpha and beta adrenergic effects of the stereoisomers of dobutamine","volume":"219","author":"Ruffolo","year":"1981","journal-title":"J Pharmacol Exp Ther."},{"key":"10.1016\/j.medine.2022.03.007_bib0565","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1213\/00000539-198706000-00014","article-title":"Dopamine compared with dobutamine in experimental septic shock: relevance to fluid administration","volume":"66","author":"Vincent","year":"1987","journal-title":"Anesth Analg."},{"key":"10.1016\/j.medine.2022.03.007_bib0570","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1164\/ajrccm.154.6.8970355","article-title":"The contrasting effects of dobutamine and dopamine on gastric mucosal perfusion in septic patients","volume":"154","author":"Nevi\u00e8re","year":"1996","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.medine.2022.03.007_bib0575","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1164\/ajrccm.160.6.9708113","article-title":"Effects of dobutamine on gastric mucosal perfusion and hepatic metabolism in patients with septic shock","volume":"160","author":"Joly","year":"1999","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.medine.2022.03.007_bib0580","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1164\/ajrccm.150.2.8049810","article-title":"Effect of dobutamine on oxygen consumption and gastric mucosal pH in septic patients","volume":"150","author":"Gutierrez","year":"1994","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.medine.2022.03.007_bib0585","doi-asserted-by":"crossref","first-page":"490","DOI":"10.5935\/0103-507X.20170068","article-title":"The spectrum of cardiovascular effects of dobutamine from healthy subjects to septic shock patients","volume":"29","author":"Dubin","year":"2017","journal-title":"Rev Bras Ter Intensiva."},{"key":"10.1016\/j.medine.2022.03.007_bib0590","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/01.CCM.0000198107.61493.5A","article-title":"The effects of dobutamine on microcirculatory alterations in patients with septic shock are independent of its systemic effects","volume":"34","author":"De Backer","year":"2006","journal-title":"Crit Care Med."},{"key":"10.1016\/j.medine.2022.03.007_bib0595","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1152\/japplphysiol.00886.2016","article-title":"Effects of dobutamine on intestinal microvascular blood flow heterogeneity and O2 extraction during septic shock","volume":"122","author":"Ospina-Tasc\u00f3n","year":"2017","journal-title":"J Appl Physiol (1985)."},{"key":"10.1016\/j.medine.2022.03.007_bib0600","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1056\/NEJMoa010307","article-title":"Early goal-directed therapy in the treatment of severe sepsis and septic shock","volume":"345","author":"Rivers","year":"2001","journal-title":"N Engl J Med."},{"key":"10.1016\/j.medine.2022.03.007_bib0735","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1056\/NEJMoa1401602","article-title":"A randomized trial of protocol-based care for early septic shock","volume":"370","author":"Yealy","year":"2014","journal-title":"N Engl J Med."},{"key":"10.1016\/j.medine.2022.03.007_bib0610","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1056\/NEJMoa1404380","article-title":"Goal-directed resuscitation for patients with early septic shock","volume":"371","author":"Peake","year":"2014","journal-title":"N Engl J Med."},{"key":"10.1016\/j.medine.2022.03.007_bib0615","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJMoa1500896","article-title":"Trial of early, goal-directed resuscitation for septic shock","volume":"372","author":"Mouncey","year":"2015","journal-title":"N Engl J Med."},{"key":"10.1016\/j.medine.2022.03.007_bib0620","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0140-6736(07)61344-0","article-title":"Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial","volume":"370","author":"Annane","year":"2007","journal-title":"Lancet."},{"key":"10.1016\/j.medine.2022.03.007_bib0625","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s13054-019-2427-4","article-title":"Comparative efficacy of vasoactive medications in patients with septic shock: a network meta-analysis of randomized controlled trials","volume":"23","author":"Cheng","year":"2019","journal-title":"Crit Care."},{"key":"10.1016\/j.medine.2022.03.007_bib0630","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1097\/01.CCM.0000261889.18102.84","article-title":"Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone","volume":"35","author":"Barraud","year":"2007","journal-title":"Crit Care Med."},{"key":"10.1016\/j.medine.2022.03.007_bib0635","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1056\/NEJMoa1609409","article-title":"Levosimendan for the Prevention of Acute Organ Dysfunction in Sepsis","volume":"375","author":"Gordon","year":"2016","journal-title":"N Engl J Med."},{"key":"10.1016\/j.medine.2022.03.007_bib0640","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1007\/s00134-019-05731-w","article-title":"Levosimendan in septic shock in patients with biochemical evidence of cardiac dysfunction: a subgroup analysis of the LeoPARDS randomised trial","volume":"45","author":"Antcliffe","year":"2019","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.medine.2022.03.007_bib0645","doi-asserted-by":"crossref","first-page":"e019338","DOI":"10.1136\/bmjopen-2017-019338","article-title":"Effect of levosimendan on mortality in severe sepsis and septic shock: a meta-analysis of randomised trials","volume":"8","author":"Chang","year":"2018","journal-title":"BMJ Open."},{"key":"10.1016\/j.medine.2022.03.007_bib0650","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13613-019-0498-7","article-title":"Current use of vasopressors in septic shock","volume":"9","author":"Scheeren","year":"2019","journal-title":"Ann Intensive Care."},{"key":"10.1016\/j.medine.2022.03.007_bib0740","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13054-019-2420-y","article-title":"Broad spectrum vasopressors: a new approach to the initial management of septic shock?","volume":"23","author":"Chawla","year":"2019","journal-title":"Crit Care."},{"key":"10.1016\/j.medine.2022.03.007_bib0660","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1164\/rccm.201806-1034OC","article-title":"Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER). A Randomized Trial","volume":"199","author":"Permpikul","year":"2019","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.medine.2022.03.007_bib0665","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1186\/s13054-014-0532-y","article-title":"Early versus delayed administration of norepinephrine in patients with septic shock","volume":"18","author":"Bai","year":"2014","journal-title":"Crit Care."},{"key":"10.1016\/j.medine.2022.03.007_bib0670","doi-asserted-by":"crossref","first-page":"R97","DOI":"10.1186\/cc13868","article-title":"Timing of vasopressor initiation and mortality in septic shock: A cohort study","volume":"18","author":"Beck","year":"2014","journal-title":"Crit Care."},{"key":"10.1016\/j.medine.2022.03.007_bib0675","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1097\/CCM.0000000000000520","article-title":"Interaction between fluids and vasoactive agents on mortality in septic shock: a multicenter, observational study","volume":"42","author":"Waechter","year":"2014","journal-title":"Crit Care Med."},{"key":"10.1016\/j.medine.2022.03.007_bib0680","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13054-020-2756-3","article-title":"Effects of very early start of norepinephrine in patients with septic shock: a propensity score-based analysis","volume":"24","author":"Ospina-Tasc\u00f3n","year":"2020","journal-title":"Crit Care."},{"key":"10.1016\/j.medine.2022.03.007_bib0685","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jcrc.2019.11.004","article-title":"Delayed vasopressor initiation is associated with increased mortality in patients with septic shock","volume":"55","author":"Colon Hidalgo","year":"2020","journal-title":"J Crit Care."},{"key":"10.1016\/j.medine.2022.03.007_bib0690","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/emp2.12060","article-title":"Time to vasopressor initiation and organ failure progression in early septic shock","volume":"1","author":"Black","year":"2020","journal-title":"J Am Coll Emerg Physicians Open."},{"key":"10.1016\/j.medine.2022.03.007_bib0745","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1186\/s13054-020-03204-x","article-title":"Timing of norepinephrine initiation in patients with septic shock: a systematic review and meta-analysis","volume":"24","author":"Li","year":"2020","journal-title":"Crit Care."},{"key":"10.1016\/j.medine.2022.03.007_bib0700","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s13054-021-03711-5","article-title":"Norepinephrine potentiates the efficacy of volume expansion on mean systemic pressure in septic shock","volume":"25","author":"Adda","year":"2021","journal-title":"Crit Care."},{"key":"10.1016\/j.medine.2022.03.007_bib0750","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/1742-6723.13394","article-title":"Initiation of vasopressor infusions via peripheral versus central access in patients with early septic shock: a retrospective cohort study","volume":"32","author":"Delaney","year":"2020","journal-title":"Emerg Med. Australas."},{"key":"10.1016\/j.medine.2022.03.007_bib0710","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/1742-6723.13469","article-title":"The Australasian Resuscitation In Sepsis Evaluation: Fluids or vasopressors in emergency department sepsis (ARISE FLUIDS), a multi-centre observational study describing current practice in Australia and New Zealand","volume":"32","author":"Keijzers","year":"2020","journal-title":"Emerg Med Australas."},{"key":"10.1016\/j.medine.2022.03.007_bib0715","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1177\/1060028018765187","article-title":"Evaluating Vasopressor Discontinuation Strategies in Patients With Septic Shock on Concomitant Norepinephrine and Vasopressin Infusions","volume":"52","author":"Musallam","year":"2018","journal-title":"Ann Pharmacother."},{"key":"10.1016\/j.medine.2022.03.007_bib0720","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13054-018-2034-9","article-title":"Incidence of hypotension according to the discontinuation order of vasopressors in the management of septic shock: a prospective randomized trial (DOVSS)","volume":"22","author":"Jeon","year":"2018","journal-title":"Crit Care."}],"container-title":["Medicina Intensiva (English Edition)"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173572724000043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173572724000043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T02:38:02Z","timestamp":1761878282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173572724000043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":73,"alternative-id":["S2173572724000043"],"URL":"https:\/\/doi.org\/10.1016\/j.medine.2022.03.007","relation":{},"ISSN":["2173-5727"],"issn-type":[{"value":"2173-5727","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"F\u00e1rmacos vasoactivos en el tratamiento del shock s\u00e9ptico","name":"articletitle","label":"Article Title"},{"value":"Medicina Intensiva (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medine.2022.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Espa\u00f1a, S.L.U. and SEMICYUC. All rights reserved.","name":"copyright","label":"Copyright"}]}}